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for Prosthetic Aortic Valve Function
Sagit Ben Zekry, MD,* Robert M. Saad, MD,* Mehmet Özkan, MD,†
Maie S. Al Shahid, MD,‡ Mauro Pepi, MD,§ Manuela Muratori, MD,§ Jiaqiong Xu, PHD,
Stephen H. Little, MD,* William A. Zoghbi, MD*
Houston, Texas; Istanbul, Turkey; Riyadh, Saudi Arabia; and Milan, Italy
O B J E C T I V E S We sought to evaluate whether ejection dynamics, particularly acceleration time (AT)
and the ratio of AT to ejection time (ET), can differentiate prosthetic aortic valve (PAV) stenosis from
controls and prosthesis–patient mismatch (PPM).
B A C KG ROUND Diagnosing PAV stenosis, especially in mechanical valves, may be challenging and
has signiﬁcant clinical implications.
METHOD S Doppler echocardiography was quantitated in 88 patients with PAV (44 mechanical and
44 bioprosthetic; age 63  16 years; valve size range 18 to 25 mm) of whom 22 patients had
documented PAV stenosis, 22 had PPM, and 44 served as controls. Quantitative Doppler parameters
included ejection dynamics (AT, ET, and AT/ET) and conventional PAV parameters.
R E S U L T S Patients with PAV stenosis had signiﬁcantly lower effective oriﬁce area (EOA) values and
higher gradients compared with controls and PPM. Flow ejection parameters (AT and AT/ET) were
signiﬁcantly longer in the stenotic valves compared with PPM and controls (respective values for AT: 120 
24 ms, 89  16 ms, and 71  15 ms; for AT/ET: 0.4, 0.32, and 0.3, p  0.001). Patients with PPM had
gradients and ejection dynamics that were intermediate between normal and stenotic valves.
Receiver-operator characteristic (ROC) curve analysis showed that AT and AT/ET discriminated PAV
stenosis from PPM and controls (area under ROC curve 0.92 and 0.88, respectively). Combining AT with
the conventional Doppler velocity index gave the highest area under the curve of 0.98 but was not
statistically different from that of AT alone (p  0.12). A cutoff of AT  100 ms had a sensitivity and
speciﬁcity of 86% for identifying PAV stenosis; for an AT/ET  0.37, the sensitivity and speciﬁcity were
96% and 82%, respectively. Analysis by valve type (mechanical and biological) revealed similar results;
however, biological valves had slightly higher areas under the curve for all systolic time intervals.
CONC L U S I O N S Ejection dynamics through PAV, particularly AT and AT/ET, are reliable angle-
independent parameters that can help evaluate valve function and identify PAV stenosis. (J Am Coll
Cardiol Img 2011;4:1161–70) © 2011 by the American College of Cardiology Foundation
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he assessment of prosthetic aortic valve
(PAV) function remains a challenge. This
stems from the variability in the measured
pressure gradients, which depends on flow,
n addition to the wide variety of prosthetic valve
ypes and sizes (1-14). Derivation of an effective
rifice area (EOA) provides a parameter that is
ess dependent on flow but still relies on knowl-
dge of valve size and type (1,2,9,12). Clinically,
nowledge of valve size and type may not be
eadily available during an echocardiographic ex-
mination, a lingering challenge in evaluation of
rosthetic valve function. A simple parameter
hat complements assessment of PAV function
nd that could overcome these limitations would
e desirable.
In native aortic stenosis, early studies have
escribed changes in ejection flow dynamics
across the valve that occur with worsen-
ing severity of stenosis: a prolongation of
ejection time (ET), delayed peak veloc-
ity, or acceleration time (AT) with a
resultant rounded contour of the Dopp-
ler jet velocity profile. These systolic
time intervals correlated with the sever-
ity of the stenotic valves (7,8,11). We
postulated that PAV ejection dynamics,
particularly acceleration time, and the
ratio of AT to ET can differentiate PAV
stenosis from patients with normal pros-
thetic valve function and those with
prosthesis–patient mismatch (PPM).
M E T H O D S
Patient population. Echocardiographic and
Doppler studies of patients with PAV were re-
viewed from the database of The Methodist Hos-
pital, Houston, Texas; Kos¸uyolu Kartal Heart
Training and Research Hospital, Istanbul, Tur-
key; King Faisal Specialist Hospital and Research
Center, Riyadh, Saudi Arabia; and Centro Car-
diologico Monzino, IRCCS, Milan, Italy, to
identify patients with suspected PAV stenosis, as
the incidence of this entity is uncommon, partic-
ularly in mechanical valves. Patients were identi-
fied as having PAV stenosis if they had a high
pressure gradient, a reduced EOA below 1 cm2
(11,12), as well as confirmation of PAV stenosis
at surgery or, in the very few cases of patients
with mechanical valves not undergoing surgery,
resolution of the high gradient and improvement
x
ow
ein EOA after thrombolytic therapy. Anothercohort with a similar number of patients was
identified from The Methodist Hospital database
with severe PPM. These were defined as patients
with normal functioning PAV, high peak velocity
(3 m/s), and mean gradient (25 mm Hg),
normal EOA for the valve type and size but
significantly reduced indexed EOA to body sur-
face area (BSA), 0.65 cm2/m2 (12). Patients
ith PPM also had further diagnostic studies
either with transesophageal echocardiography or
uoroscopy) to confirm no obstruction of the
alve. Last, a third cohort of individuals with
ormal PAV function served as controls. These
atients were chosen to match those with PAV
tenosis (2:1) with respect to age, sex, and valve
ype. Normal valve function was defined as hav-
ng a normal pressure gradient and EOA in the
eported range for the valve type and size (9,12),
ithout evidence of regurgitation. To further
nsure normality of function, these patients had
o have their echo/Doppler studies within 3
onths after their aortic valve replacement and
ith no signs or symptoms of PAV dysfunction.
atients with more than mild PAV regurgitation
ere excluded from analysis, as were those with
oncomitant prosthetic mitral valves or poor im-
ge quality.
Echocardiographic study. Two-dimensional trans-
thoracic echocardiographic and Doppler studies
were obtained with clinical ultrasound machines
equipped with 2.5 to 3.5 MHz transducers using
standard views. Pulsed Doppler in the left ven-
tricular outflow tract (LVOT) from the apical
window was used to evaluate flow. Continuous
wave Doppler recording of flow through the PAV
was performed from the apical, right parasternal,
suprasternal, and subcostal windows to minimize
the effect of Doppler angulation with flow.
Doppler recordings were performed at a sweep
speed of 100 mm/s.
The studies from all centers were sent to the
Methodist Hospital, and then reviewed and quanti-
tated by a single observer (S.B.Z.) on an offline station
(Digisonics Inc., Houston, Texas). All measurements
represent an average of 3 cardiac cycles for patients in
sinus rhythm and at least 6 cardiac cycles for patients
in atrial fibrillation.
Standard echocardiographic and Dopplermeasurements.
Parasternal long-axis view was used for measur-
ing the aortic annulus diameter in early systole,
just below the insertion of the PAV. Using the
pulsed wave Doppler recording in the LVOT, theA B B R E V I A T I O N S
A N D A C R O N YM S
AT acceleration time
BSA body surface area
VI Doppler velocity inde
EOA effective orifice area
ET ejection time
LVOT left ventricular outfl
ract
AV prosthetic aortic valv
PM prosthesis–patient
ismatch
OC receiver-operator
haracteristictime-velocity integral (TVI) was calculated.
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1163Figure 1. Systolic Time Intervals in Controls and Stenotic PAV
Note the rounded ﬂow velocity curve for the obstructed valve (right) and the early peaking of the velocity in the normal valve
(left). AT  acceleration time; ET  ejection time; PAV  prosthetic aortic valve.Table 1. Baseline Clinical and Echocardiographic Characteristics
Parameters
Control PAV
(n  44)
Prosthesis–Patient Mismatch
(n  22)
PAV Stenosis
(n  22) p Value
Age, yrs 65 17 65 13 59 16 0.28
Male 32 (73) 19 (86) 13 (59) 0.13
Weight, kg 82 26 100 26* 82 22 0.03
Height, cm 170 13 170 13 173 10 0.28
BSA, m2 1.9 0.3 2.2 0.3* 1.9 0.3† 0.016
Systolic blood pressure, mm Hg 128 19 125 13 121 19 0.39
Diastolic blood pressure, mm Hg 71 15 67 8 67 12 0.44
Heart rate, beats/min 87 16 78 18 84 20 0.14
Rhythm
Sinus 33 (75.0) 19 (86.4) 19 (86.4) 0.6
Atrial ﬁbrillation 9 (20.5) 3 (13.6) 3 (13.6)
Paced 2 (4.5) 0 0
Valve type
Biological 22 (50) 11 (50) 11 (50) 1
Mechanical 22 (50) 11 (50) 11 (50)
Valve size, mm 22.6 1.6 21.4 1.9* 21.0 2.1 0.019
Range (19–25) (19–25) (19–25)
Echocardiography
LVOT area, cm2 3.4 0.7 3.5 0.9 2.9 0.3*† 0.007
EOA, cm2 1.7 0.55 1.3 0.35* 0.68 0.20*† 0.001
EOA/BSA, cm2/m2 0.92 0.3 0.61 0.1* 0.37 0.1*† 0.001
Left ventricular ejection fraction, % 55 15 66 9* 50 15† 0.001
TVI LVOT, cm2 18.6 4.4 26 4.9* 22.1 6.7*† 0.001
Stroke volume, ml 64 21 89 18* 64 20† 0.001
TVI aortic, cm2 40.4 13.5 69.5 11.5* 95.9 28.1*† 0.001
Peak velocity LVOT, cm/s 106 19 130 26* 93 24† 0.001
Peak velocity across PAV, cm/s 250 61 386 42* 441 80*† 0.001
Peak pressure across PAV, mm Hg 26 12 60 13* 81 28*† 0.001
Mean pressure across PAV, mm Hg 14 7 32 8* 49 19*† 0.001
Values are n (%) or mean  SD. *p  0.05 vs. normal PAV. †p  0.05 vs. prosthesis–patient mismatch.
BSA  body surface area; EOA  effective oriﬁce area; LVOT  left ventricular outﬂow tract; PAV  prosthetic aortic valve; TVI  time-velocity integral.
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1164Stroke volume in the LVOT was derived using
the TVILVOT, assuming a circular geometry of
the LVOT. Left ventricular function was esti-
e 2. Effective Oriﬁce Area
ive oriﬁce area (EOA) in controls, patients with prosthesis–patient
atch, and with PAV stenosis. Means are shown. Patients with ste-
PAV had the lowest EOA; the largest EOA was seen in the con-
Abbreviation as in Figure 1.
e 3. Peak Pressure Gradient
pressure gradient across the prosthetic aortic valve in controls,
ts with prosthesis–patient mismatch (PPM), and with prosthetic
valve stenosis. Means are shown. The highest peak gradient was
in the stenotic group, and the lowest peak pressure was seen inontrols.mated by the reader. From the continuous wave
jet recording, peak velocity was measured and
mean gradient was calculated using the modified
Bernoulli equation. The TVI of the aortic jet by
continuous wave was also measured to derive an
effective orifice area (EOA) using the continuity
equation (1,2) as (stroke volume)/TVIjet. An
ndexed EOA to BSA was calculated as EOA/
SA. A Doppler velocity index (DVI), a simpli-
cation of the continuity equation (1) was calcu-
ated as TVILVOT/TVIjet.
Systolic time intervals. The systolic time intervals
f flow through the PAV were measured using
he velocity curve from the continuous wave
oppler recording (Fig. 1). ET was measured as
he time from onset to end of systolic flow across
he prosthetic valve. The time interval from the
eginning of systolic flow to its peak velocity was
efined as AT. The ratio of AT/ET was then
alculated.
Intraobserver and interobserver variability. To assess
the intraobserver and interobserver variability of
systolic time intervals, a total of 15 studies were
quantitated by the same observer on 2 different
occasions (from the same echocardiographic study,
not necessarily the same beats) in a random order
and by another observer. The 15 cases included 5
controls, 5 patients with PPM, and 5 with pros-
thetic valve obstruction; to have a wide range of
values. Variability was expressed as the difference
between the measurements and percent error (dif-
ference in measurement divided by the mean value
of the 2 observations, expressed as percent). Actual
values were also correlated using linear regression
analysis.
Statistical analysis. Continuous variables are pre-
sented as mean  SD, and categorical variables as
numbers (percentages). One-way analysis of vari-
ance was used with post hoc Tukey honestly
significant difference (HSD) test adjustment for
multiple comparisons among the different groups.
Categorical variables were compared using chi-
square test. A receiver-operator characteristic (ROC)
curve was plotted to determine the best AT, ET,
and AT/ET cutoff value for identifying PAV
stenosis. This cutoff was determined as the value
providing a balance between sensitivity and spec-
ificity, or at most, a slightly higher sensitivity
because of the clinical implication of detecting
valve stenosis. The area under the ROC curve
was calculated. The areas under 2 or more corre-
lated ROC curves were compared (15). MultipleFigur
Effect
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noticFigur
Peak
patien
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notedlinear regression models were developed to study
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(AT, ET, AT/ET) and the following indepen-
dent variables: EOA, heart rate, stroke volume,
ejection fraction, age, and sex. Statistical analysis
was performed with SPSS version 15.0 (SPSS
Inc., Chicago, Illinois) and STATA version 10
(College Station, Texas). A p value 0.05 was
considered significant.
R E S U L T S
Baseline patient characteristics are summarized in
Table 1. The 3 groups were similar in age, sex,
systemic hemodynamics, and rhythm. All mechan-
ical valves were bileaflet valves. A wide range of
valve sizes was observed in all groups; compared
with controls, patients with mismatch had smaller
valve sizes, larger stroke volumes, and larger body
surface areas.
Doppler parameters. Conventional parameters of
alve function are shown in Figures 2, 3, and 4. In
omparison with patients with normal valves and
hose with PPM, patients with PAV stenosis had
ignificantly lower EOA and higher pressure
radients across the prosthetic valve (Figs. 2 and
). Similarly, the lowest DVI values were noted
n patients with PAV stenosis (Fig. 4). Using a
utoff of 0.25, DVI had a sensitivity, specificity,
ositive and negative predictive values, and accuracy
f 59%, 100%, 100%, 88%, and 90%, respectively.
Systolic time intervals. Ejection parameters for pa-
tients with normal PAV function, PPM, and
stenotic valves are presented in Figure 5. Stenotic
valves had significantly longer AT and higher
AT/ET compared with PPM and normal valves.
Of interest is that AT/ET was similar between
patients with normal valves and those with PPM;
both significantly lower than in PAV stenosis. In
contrast, ejection time was longer in PPM and
stenotic PAV compared with normal valves, but
was not different between PPM and stenotic
PAVs (Fig. 5). Similar results were obtained if
patients with PAV stenosis and very high gradi-
ents (peak gradient 100 mm Hg) were ex-
cluded. ROC analysis (Fig. 6) showed that AT,
ET, and AT/ET could discriminate PAV steno-
sis from controls and those with PPM. The
largest area under the ROC curve for systolic
time intervals was seen with AT (0.92) followed
by AT/ET (0.88). ET had the lowest area under
the ROC curve (0.73). The area under the ROC
curve for DVI was 0.96. Combining AT with the
conventional DVI gave the highest area under the bcurve of 0.98 but was not statistically different
from that of AT alone (p  0.12). The AT/ET
atio did not add incremental value over the
ombination of AT and DVI. Table 2 summa-
izes the analysis and lists the derived best cutoff
alues for systolic time intervals, balancing sen-
itivity and specificity for valve stenosis as well as
hose cutoff values with 100% specificity of PAV
tenosis. A cutoff of AT  100 ms had a
ensitivity and specificity of 86% for PAV steno-
is. An AT/ET ratio of 0.37 allowed the identi-
cation of stenotic PAV with 96% sensitivity and
2% specificity. An AT 128 ms and AT/ET of
0.58 were 100% specific for PAV stenosis.
A ROC curve analysis of systolic time intervals
as also performed for the detection of PAV
tenosis by valve type (mechanical and biological)
Table 3). In general, similar results were ob-
erved, and biological valves had slightly higher
rea under curve for all systolic time intervals.
Multiple linear regression analysis. Multiple linear
egression analysis was performed to evaluate the
eterminants of each of the systolic time intervals
AT, ET, and AT/ET) and their relation to
OA, stroke volume, heart rate, ejection fraction,
ge, and sex. Results of the models are shown in
ables 4, 5, and 6. The AT and ET models had
Figure 4. Doppler Velocity Index
Doppler velocity index (DVI) in controls, patients with PPM, and
stenosis. Means are shown. The lowest DVI values were noted in
patients with PAV stenosis. Both groups of controls and the pati
with PPM valves had a normal range of DVI. Abbreviation as in
Figures 1 and 3.PAV
entsoth an R2 of 0.64, accounting for 64% of the
m
w
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1166observed variability in these parameters. The
AT/ET model was less strong, with an R2 of
0.35. For all systolic time intervals, the most
significant determining variable was EOA (larg-
est coefficient; quadratic relation), followed by
stroke volume; ejection fraction was less of a
determinant and only for AT.
Intraobserver and interobserver variability. Measure-
ents of AT, ET, and AT/ET correlated well
hen repeated by the same observer: correlation
oefficients r  0.98, 0.99, and 0.94, respectively.
Correlations between the 2 observers for AT, ET,
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Figure 5. Systolic Ejection Parameters in Controls, Patients With
(A) Acceleration time (AT); (B) ejection time (ET); and (C) AT/ET. Ste
compared with PPM and control valves. Abbreviation as in Figure 3and AT/ET were 0.91, 0.94, and 0.88, respectively.Mean differences between measurements of AT,
ET, and AT/ET for the same observer were 0  7
ms, 1  8 ms, and 0.00  0.02, respectively, and
between observers were 2  15 ms, 9  17 ms,
and 0.01  0.04, respectively. Mean percent error
in measurements of AT, ET, and AT/ET for the
same observer were0.5 7%, 0.5 3%, and 1
7%, respectively, and between observers were 1.9 
11.6%, 3.8  6.4%, and 5.8  9.6%, respectively.
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1167PAV from those with normal prosthetic valve
function and those with PPM. An AT 100 ms
and AT/ET over 0.37 can identify PAV stenosis
with good accuracy. These simple measurements
complement conventional parameters of prosthetic
valve function, offering an angle-independent
Doppler measure of valve function.
Prosthetic aortic valve stenosis. Similar to native
valve stenosis, the velocity and gradient across
PAVs increase with worsening severity of ob-
struction, along with prolongation of the ejection
time and delay in reaching the maximal velocity
across the valve (prolonged AT), leading to a
rounded jet velocity contour (Fig. 1). These
ejection dynamics, in contrast to assessment of
gradients, are angle-independent and relatively
simple to acquire and measure. Earlier, Rothbart
et al. (11) reported a significantly longer AT (116 
15 ms) in patients with stenotic bioprosthetic
PAV. Minimal correlation between AT and valve
size was found; the study included mostly valve
sizes above 23 mm. The authors offered 4 vari-
ables to identify normal PAV function: AT
(100 ms), peak gradient (48 mm Hg), mean
gradient (25 mm Hg), and EOA (1.1 cm2).
wo abnormal measurements were consistent
ith stenotic bioprosthetic PAV (11). The pres-
nt investigation corroborates these findings and
xtends these observations to mechanical pros-
hetic valves. Our results provide further support
o the new guidelines for evaluation of prosthetic
alves— both mechanical and bioprosthetic—
hich were based on the mentioned observations
n bioprosthetic valves and our preliminary ob-
ervations in mechanical valves (12). Similar to
hat the guidelines postulated (12) and now
ereby validated, a combination of AT and DVI
ives an excellent assessment of valve function,
ifferentiating valve stenosis from PPM and nor-
al prostheses (area under the ROC curve 
.98). In addition to AT, the ratio AT/ET was
lso found to be a helpful parameter to discrim-
nate stenotic PAV from both normal and PPM
Table 2. ROC Analysis: Differentiation of PAV Stenosis From Co
Parameter AUC (95% CI)
Best Cutoff to Disc
Value Sensitivity (%)
AT, ms 0.92 (0.83–1.00) 100 86
ET, ms 0.73 (0.60–0.86) 275 73
AT/ET 0.88 (0.78–0.97) 0.37 96
AT  acceleration time; AT/ET  ratio of acceleration time to ejection time;
PPM  prosthesis–patient mismatch; PPV  positive predictive value; ROC  realves. PAV with better hemodynamic profiles
ere previously reported to have lower AT/ET
alues (3). The present cohort included a wide
ange of valve sizes (19 to 25 mm), making these
eterminations applicable in a wide range of
linically implanted valves. Last, an advantage of
ystolic time intervals is that they are indepen-
ent of ultrasound beam angulation with jet
elocity, an inherent factor or possible limitation
n all other measures of prosthetic valve function,
uch as velocity, gradient, EOA, and DVI.
Prosthesis–patient mismatch. PPM is an important
cause of elevated velocity and gradients across
normally functioning prosthetic valves. Calcu-
lated EOA is in the normal range for the type and
size of the particular prosthetic valve, but is too
small for the selected patient (reduced EOA/
BSA). In bileaflet mechanical valves, EOA may
be smaller than that derived hemodynamically
because of localization of velocity and gradient
Figure 6. ROC Curve
Receiver-operator characteristic (ROC) curves to differentiate PAV st
sis from controls and patients with PPM based on measurements o
ET, the ratio AT/ET, and Doppler velocity index. Abbreviations as in
Figures 1 and 3.
ls and PPM
inate PAV Stenosis From Controls and PPM
Cutoff
ociﬁcity (%) Accuracy (%) PPV (%) NPV (%)
86 85 66 95
68 74 48 85
82 85 64 98
 area under the curve; CI  conﬁdence interval; ET  ejection time; NPV  neno-
f AT,ntro
rim
for 100% Speciﬁcity
f PAV StenosisSpe
128
355
0.58
AUC egative predictive value;
ceiver-operator characteristic; other abbreviation as in Table 1.
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1168between the 2 leaflets (12). However, normal
values already incorporate this phenomenon. It is
crucial to distinguish PPM from stenotic PAV.
In the present study, patients with PPM had
several parameters (gradients, DVI, EOA) inter-
mediate between controls and those with severe
stenosis. Similar observations were seen with AT
measurements, probably because of higher stroke
volume through the prosthesis. Of interest is that
AT/ET correctly identified PAV function as
normal in patients with PPM, because AT/ET
was similar in controls and in PPM. This most
likely is because both AT and ET increase with
Table 3. ROC Curve Analysis for Differentiation of PAV Stenosis
Parameter
Bioprosthetic Valves
AUC (95% CI) Value* Sensitivity (%) Speciﬁc
AT, ms 0.97 (0.92–1.00) 100 91 87
ET, ms 0.79 (0.61–0.96) 280 73 70
AT/ET 0.91 (0.81–1.00) 0.37 91 91
*Best cutoff to discriminate PAV stenosis from controls and PPM.
Abbreviations as in Tables 1 and 2.
Linear Regression Model for AT Model (R2  64%)
Coefﬁcient (Standardized
Regression Coefﬁcient) 95% CI p Value
73.11 (1.67) 96.46 to49.76 0.001
13.62 (1.06) 6.71 to 20.52 0.001
in 0.13 (0.08) 0.38 to 0.12 0.29
0.46 (0.40) 0.25 to 0.67 0.001
1.64 (0.92) 0.12 to 3.16 0.03
% 0.02 (0.97) 0.03 to0.002 0.02
0.18 (0.11) 0.42 to 0.06 0.14
2.14 (0.04) 11.19 to 6.91 0.64
bles 1 and 2.
Linear Regression for ET Model (R2  64%)
Coefﬁcient (Standardized
Regression Coefﬁcient) 95% CI p Value
81.75 (1.06) 122.90 to40.60 0.001
15.20 (0.67) 2.98 to 27.42 0.01
in 1.31 (0.47) 1.75 to0.87 0.001
2.93 (1.46) 1.48 to 4.38 0.001
l2 0.01 (1.14) 0.02 to0.006 0.002
0.39 (0.12) 0.88 to 0.11 0.12
0.38 (0.13) 0.03 to 0.80 0.07
16.56 (0.16) 32.43 to 0.69 0.04bles 1 and 2.the high flow observed in patients with PPM. A
ratio of AT to ET may thus still be in the normal
range. A support for this rationale is that AT/ET
had the lowest significant relation to stroke vol-
ume in the 3 models. Thus, a combination of AT
and AT/ET may be the most helpful in the
overall evaluation of prosthetic valve function
using systolic time intervals. Although EOA
determination is crucial in evaluating PPM, it
becomes problematic when the valve size and
type are not known, which is not an infrequent
situation. Systolic time interval parameters, par-
ticularly AT and AT/ET would be helpful in
evaluating valve function in these circumstances.
Determinants of systolic time intervals. Various fac-
ors were evaluated to assess determinants of
ystolic time intervals in PAVs. The major deter-
inant for AT, ET, and AT/ET was EOA of the
alve. Stroke volume through the valve was also a
eterminant, but to a much lesser degree, as
udged by the coefficient value (Tables 3, 4, and 5): for
example, for any increase of 10 ml in stroke
volume, AT and AT/ET values will have a minor
increase of 4.6 ms and 0.01, respectively. An even
lesser influence of ejection fraction was noted for
AT (Table 3). To demonstrate this relation, we
can assess, for example, the difference in AT
values among patients with ejection fractions of
30%, 50%, and 70% (assuming all other parame-
ters in the model are kept the same). Compared
with a patient with an ejection fraction of 50%, a
patient with an ejection fraction of 30% will have
a shorter AT by 5.6 ms, whereas for a patient
with an ejection fraction of 70%, the AT will be
8 ms longer.
For the ET model, heart rate was a significant
determinant, in addition to EOA and stroke vol-
ume (Table 4). Using the model, any increase in
heart rate by 10 beats/min results in a decrease in
ET by 13 ms, whereas an increase in stroke volume
by 10 ml results in an increase in ET by 29 ms. The
influence of heart rate and stroke volume on ET in
m Controls and PPM in Biological and Mechanical Valves
Mechanical Valves
%) AUC (95% CI) Value* Sensitivity (%) Speciﬁcity (%)
0.86 (0.69–1.00) 105 82 97
0.65 (0.44–0.86) 272 73 70
0.83 (0.67–1.00) 0.38 82 91Fro
ity (Table 4. Multiple
Independent
Variable
EOA, cm2
EOA2, cm4
Heart rate, beats/m
Stroke volume, ml
Ejection fraction, %
Ejection fraction2,
Age, yrs
MaleTable 5. Multiple
Independent
Variable
EOA, cm2
EOA2, cm4
Heart rate, beats/m
Stroke volume, ml
Stroke volume2, m
Ejection fraction, %
Age, yrs
MalePAVs is not surprising because it has been docu-
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1169mented in native aortic valve stenosis (16). Simi-
larly, ET has shown a relationship to cardiac index,
stroke volume, and ejection fraction in PAV (7).
Thus, ET as a sole parameter of function should be
used carefully in PAVs.
Study limitations. The number of observations in
he stenotic PAVs may be relatively small. How-
ver, this condition, particularly in mechanical
alves, is uncommon. The present series stems
rom collaboration among the mentioned institu-
ions to achieve this goal. Furthermore, we re-
uired convincing documentation of prosthetic
alve obstruction. Because the study is a retro-
pective study and the study participants were
dentified by institutional staff, there exists the
otential for a sampling bias; the generalization
f the current findings may therefore be tempered
ending further validation and experience. The
ystolic time intervals are complementary param-
ters for assessment of PAV function and should
e used in conjunction with other indexes such as
ressure gradients, EOA, and DVI. For patients
here valve obstruction is in question, confirma-
ion of the abnormality in valve motion is under-
aken with transesophageal echocardiography
nd/or fluoroscopy or computer tomography (12).
lthough systolic time intervals are related pre-
ominantly to EOA, ventricular function (stroke
olume/ejection fraction), as well as heart rate,correction to the Bernoulli equation Baumgartner H. NC O N C L U S I O N S
The present findings over a wide range of condi-
tions show that systolic time intervals, particularly
AT and the ratio of AT/ET, are reliable, angle-
independent parameters that can enhance the eval-
uation of prosthetic valve function and help identify
PAV stenosis.
Acknowledgment
The authors thank Hen Hallevi, MD, for his
assistance.
Reprint requests and correspondence: Dr. William A.
oghbi, Cardiovascular Imaging Institute, The Method-
st DeBakey Heart and Vascular Center, 6550 Fannin Street,
M 677, Houston, Texas 77030. E-mail: wzoghbi@
Table 6. Multiple Linear Regression for AT/ET Model (R2  35%
Independent
Variable
Coefﬁcient (Standardized
Regression Coefﬁcient) 95% C
EOA, cm2 0.16 (1.19) 0.25 to0.
EOA2, cm4 0.03 (0.80) 0.003 to 0.0
Heart rate, beats/min 0.0007 (0.16) 0.0002 to 0
Stroke volume, ml 0.001 (0.30) 0.0002 to 0
Ejection fraction, % 0.00005 (0.01) 0.001 to 0.0
Age, yrs 0.001 (0.30) 0.002 to0
Male 0.004 (0.02) 0.04 to 0.03
Abbreviations as in Tables 1 and 2.ay carry an influence, albeit much smaller. tmhs.org.1
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